Bain Capital

About us

Bain Capital Life Sciences was founded in 2016 and builds on Bain Capital’s four decades of healthcare and life sciences investing across private equity, public equity, credit, venture capital, and real estate. The Life Sciences team invests in biopharmaceutical, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that drive medical innovation to improve the lives of patients with unmet medical needs.

Life Sciences by numbers

$6.5B+
Assets under management1AUM is estimated and represented as of June 30, 2025.
70+
Investments globally1Data as of June 1, 2025
20+
Medicines or technologies approved or launched1Data as of June 1, 2025

Our team has extensive public and private investing expertise, operating and consulting experience, and colleagues who bring deep scientific and medical insights. The team’s differentiated skillset enables us to invest capital at scale and provide value-added strategic support to clinical and commercial-stage companies around critical phases of value creation.

  • Life Sciences team
  • Boston